GenEdit is sailing toward the clinic with a new name and fresh funding.  | GenEdit is sailing toward the clinic with a new name and fresh funding. Rebranded as BreezeBio, the biotech has raised $60 ...

New therapeutics in development for autoimmune disease and oncologyLead therapeutic BRZ-101 designed to restore immune tolerance in type 1 diabetes, advancing into IND-enabling studiesExpanding ...

Aardvark Therapeutics is voluntarily pausing a Phase 3 trial of a drug to treat hyperphagia in patients with Prader-Willi Syndrome. The biopharmaceutical company said it is pausing the trial after ...

FBI uses investigative genetic genealogy to analyze DNA in Nancy Guthrie kidnapping case, the same technology that solved ...

Pima County Sheriff's Department Sheriff Chris Nanos says they will use forensic genetic genealogy—uploading DNA profiles to public sites like 23andMe and AncestryDNA—in their search for Nancy Guthrie ...

In a TED Talk delivered over a decade ago, she challenged the myth that beauty equals happiness. She openly admitted that she “won the genetic lottery” and benefited from a system that historically ...

The company has shed its former “GenEdit” name and strategy in favor of a plan to develop its own medicines, starting with a ...

O3, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets ...

Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it ...

How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.

NEW YORK and TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus ” or the “Company ”) (CSE: IAN, OTCID: ITHUF), ...

Men’s Health Network debuts “My Cancer, My Plan” Podcast to help men navigate diagnosis, treatment decisions, and ...